This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Loehrer PJ Sr et al. (1998) Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumour. J Clin Oncol 16: 2500–2504
Bhardwa JM et al. (2005) Assessing the size and stage of testicular germ cell tumours: 1984–2003. BJU Int 96: 819–821
Mead GM et al. (2005) A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial. Br J Cancer 93: 178–184
Shamash J et al. (1999) Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy. Ann Oncol 10: 685–692
Shamash J et al. (2005) A phase II study of irinotecan, paclitaxel and oxaliplatin (IPO) in patients with multiply relapsed germ cell tumours (GCT) [abstract]. J Clin Oncol 23 (Suppl): 4527
Acknowledgements
The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Oliver, R. High-dose chemotherapy in germ-cell cancer salvage regimens: where next?. Nat Rev Urol 2, 590–591 (2005). https://doi.org/10.1038/ncpuro0358
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0358